참고문헌
- Aparasu RR, Bhatara V : Patterns and determinants of antipsychotic prescribing in children and adolescents, 2003-2004. Curr Med Res Opin, 23:49- 56, 2007. https://doi.org/10.1185/030079906X158075
- First drug to treat irritability associated with autism. FDA Consum, 41:4, 2007.
- 조수철 : 소아정신약물학. 서울대학교출판부, 101, 147, 276, 2005.
- De Oliveira IR, Juruena MF : Treatment of psychosis: 30 years of progress. J Clin Pharm Ther, 31:523-534, 2006. https://doi.org/10.1111/j.1365-2710.2006.00784.x
- Ipser J, Stein DJ : Systematic review of pharmacotherapy of disruptive behavior disorders in children and adolescents. Psychopharmacology, 191:127-140, 2007. https://doi.org/10.1007/s00213-006-0537-6
- Luby J, Mrakotsky C, Stalets MM, et al. : Risperidone in preschool children with autistic spectrum disorders: an investigation of safety and efficacy. J Child Adolesc Psychopharmacol, 16:575-587, 2006. https://doi.org/10.1089/cap.2006.16.575
- West L, Waldrop J : Risperidone use in the treatment of behavioral symptoms in children with autism. Pediatr Nurs, 32:545-549, 2006.
- Hori T, Makabe K, Nemoto K, et al. : Hypersalivation induced by olanzapine with fluvoxamine. Prog Neuropsychopharmacol Biol Psychiatry, 30:758-760, 2006. https://doi.org/10.1016/j.pnpbp.2006.01.018
- Kontaxakis VP, Ferentinos PP, Havaki-Kontaxaki BJ, et al. : Risperidone augmentation of clozapine: a critical review. Eur Arch Psychiatry Clin Neurosci, 256:350-355, 2006. https://doi.org/10.1007/s00406-006-0643-9
- Duran JC, Greenspan A, Diago JI, et al. : Evaluation of risperidone in the treatment of behavioral and psychological symptoms and sleep disturbances associated with dementia. Int Psychogeriatr, 17:591-604, 2005. https://doi.org/10.1017/S104161020500219X
- Boyce HW, Bakheet MR : Sialorrhea: a review of a vexing, often unrecognized sign of oropharyngeal and esophageal disease. J Clin Gastroenterol, 39:89-97, 2005.
- Cheng-Shannon J, McGough JJ, Pataki C, et al. : Second-generation antipsychotic medications in children and adolescents. J Child Adolesc Psychopharmacol, 14:372-394, 2004. https://doi.org/10.1089/cap.2004.14.372
- Fernandez HH, Trieschmann ME, Friedman JH : Treatment of psychosis in Parkinson's disease: safety considerations. Drug Saf, 26:643-659, 2003. https://doi.org/10.2165/00002018-200326090-00004
- Freudenreich O, Goff DC : Antipsychotic combination therapy in schizophrenia. A review of efficacy and risks of current combinations. Acta Psychiatr Scand, 106:323-330, 2002. https://doi.org/10.1034/j.1600-0447.2002.01331.x
- Fleischhacker WW, Lemmens P, van Baelen B : A qualitative assessment of the neurological safety of antipsychotic drugs; an analysis of a risperidone database. Pharmacopsychiatry, 34:104-110, 2001. https://doi.org/10.1055/s-2001-14282
- Buitelaar JK, van der Gaag RJ, Cohen-Kettenis P, et al. : A randomized controlled trial of risperidone in the treatment of aggression in hospitalized adolescents with subaverage cognitive abilities. J Clin Psychiatry, 62:239-248, 2001. https://doi.org/10.4088/JCP.v62n0405
- Roerig JL, Mitchell JE, de Zwaan M, et al. : A comparison of the effects of olanzapine and risperidone versus placebo on eating behaviors. J Clin Psychopharmacol, 25:413-418, 2005. https://doi.org/10.1097/01.jcp.0000177549.36585.29
- Srisurapanont M, Maneeton B, Maneeton N : Quetiapine for schizophrenia. Cochrane Database Syst Rev, 2:CD000967, 2004.
- Potkin SG, Thyrum PT, Alva G, et al. : The safety and pharmacokinetics of quetiapine when coadministered with haloperidol, risperidone, or thioridazine. J Clin Psychopharmacol, 22:121-130, 2002. https://doi.org/10.1097/00004714-200204000-00004
- Mullen J, Jibson MD, Sweitzer D : A comparison of the relative safety, efficacy, and tolerability of quetiapine and risperidone in outpatients with schizophrenia and other psychotic disorders: the quetiapine experience with safety and tolerability (QUEST) study. Clin Ther, 23:1839-1854, 2001. https://doi.org/10.1016/S0149-2918(00)89080-3
- Bhana N, Foster RH, Olney R, et al. : Olanzapine: an updated review of its use in the management of schizophrenia. Drugs, 61:111-161, 2001. https://doi.org/10.2165/00003495-200161010-00011
- Koran LM, Ringold AL, Elliott MA : Olanzapine augmentation for treatment-resistant obsessivecompulsive disorder. J Clin Psychiatry, 61:514-517, 2000. https://doi.org/10.4088/JCP.v61n0709
- Guggenheimer J, Moore PA : Xerostomia: etiology, recognition and treatment. J Am Dent Assoc, 134:61-69, 2003.
- Scully C : Drug effects on salivary glands: dry mouth. Oral dis, 9:165-176, 2003. https://doi.org/10.1034/j.1601-0825.2003.03967.x
- Bergdahl M, Berhdahl J : Low unstimulated salivary flow an subjective oral dryness: association with medication, anxiety, depression, and stress. J Dent Res, 79:1652-1658, 2000. https://doi.org/10.1177/00220345000790090301
- Gupta A, Epstein JB, Sroussi H : Hyposalivation in elderly patients. J Can Dent Assoc, 72:841-846, 2006.
- Cassolato SF, Turnbull RS : Xerostomia: clinical aspects and treatment. Gerodontology, 20:64-77, 2003. https://doi.org/10.1111/j.1741-2358.2003.00064.x
- Ambudkar IS : Regulation of calcium in salivary gland secretion. Crit Rev Oral Biol Med, 11:4-25, 2000. https://doi.org/10.1177/10454411000110010301
- 이종흔, 김중수 : 구강생리학 4판. 군자출판사, 177-210, 1994.
-
Soltoff SP, McMillian MK, Cragoe EJ Jr, et al. : Effects of extracellular ATP on ion transport systems and [
$Ca^{2+}$ ]i in rat parotid acinar cells. Comparison with the muscarinic agonist carbachol. J Gen Physiol, 95:319-346, 1990. https://doi.org/10.1085/jgp.95.2.319 -
이주석, 서정택, 이정일 외 : 흰쥐 악하선 세포에서 gap junction 봉쇄제인 octanol이 타액분비 및 세포내
$Ca^{2+}$ 농 도 조절에 미치는 영향. 대한소아치과학회지, 26:399- 415, 1999. -
Grynkiewicz G, Poenie M, Tsien RY : A new generation of
$Ca^{2+}$ indicators with greatly improved fluorescence properties. J Biol Chem, 260:3440-3450, 1985. -
Uto A, Arai H, Ogawa Y : Reassessment of Fura-2 and the ratio method for determination of intracellular
$Ca^{2+}$ concentrations. Cell Calcium, 12:29-37, 1991. https://doi.org/10.1016/0143-4160(91)90082-P - Flarakos J, Luo W, Aman M, et al. : Quantification of risperidone and 9-hydroxyrisperidone in plasma and saliva from adult and pediatric patients by liquid chromatography-mass spectrometry. J Chromatogr A, 1026:175-183, 2004. https://doi.org/10.1016/j.chroma.2003.10.138
- Medori R, Mannaert E, Grnder G : Plasma antipsychotic concentration and receptor occupancy, with special focus on risperidone long-acting injectable. Eur Neuropsychopharmacol, 16:233-240, 2006. https://doi.org/10.1016/j.euroneuro.2005.10.006
- Yagiela JA, Neidle EA, Dowd FJ : Pharmacology and therapeutics for dentistry 5th edition. Mosby, 2004.
- 김경환 편 : 이우주의 약리학강의 5판. 의학문화사, 7-26, 2003.
- Bertram Katzung : Basic and clinical pharmacology 9th edition. McGraw-Hill, 2004.
- Elad S, Heisler S, Shalit M : Saliva secretion in patients with allergic rhinitis. Int Arch Allergy Immunol, 141:276-280, 2006. https://doi.org/10.1159/000095297
- Richelson E, Souder T : Binding of antipsychotic drugs to human brain receptors focus on newer generation compounds. Life Sci, 68:29-39, 2000. https://doi.org/10.1016/S0024-3205(00)00911-5
- Tumilasci OR, Cersosimo MG, Belforte JE, et al. : Quantitative study of salivary secretion in Parkinson's disease. Mov Disord, 21:660-667, 2006. https://doi.org/10.1002/mds.20784
- Edwards LL, Quigley EM, Harned RK, et al. : Characterization of swallowing and defecation in Parkinson's disease. Am F Gastroenterol, 1:15-25, 1994.
- Leopold NA, Kagel MC : Laryngeal deglutition movement in Parkinson's disease. Neurology, 48:373-376, 1997. https://doi.org/10.1212/WNL.48.2.373
- Pinnington LL, Muhiddin KA, Ellis RE, et al. : Non-invasive assessment of swallowing and respiration in Parkinson's disease. J Neurol, 247:773-777, 2000. https://doi.org/10.1007/s004150070091
- Bagheri H, Damase-Mechel C, Lapeyre-Mestre M, et al. : A study of salivary secretion in Parkinson's disease. Clin Neuropharmacol, 22:213-215, 1999.
- Beteson MC, Gibberd FB, Wilson RSE : Salivary symptoms in Parkinson's disease. Arch Neurol, 29:274-275, 1973. https://doi.org/10.1001/archneur.1973.00490280086013
- Persson M, Osterberg T, Granerus AK, et al. : Influence of Parkinson's disease on oral health. Acta Odontol Scand, 50:37-42, 1992. https://doi.org/10.3109/00016359209012744
- Proulx M, De Courval FP, Wiseman MA, et al. : Salivary production in Parkinson's disease. Mov Disord, 20:204-207, 2005. https://doi.org/10.1002/mds.20189
- 김재곤, 김영신, 백병주 외 : 타액 우식 관련 검사와 치아우식 경험과의 관계에 관한 연구. 대한소아치과학회지, 32:67-74, 2005.